See the 2019 Panama Sessions presentations

The XXXIX Regional SOLACI Sessions in Panama were an extremely successful scientific event. Renowned specialists in hemodynamics from all over Latin America presented their works and shared their knowledge in an event characterized by the utmost respect and comradeship.

Jornadas Panamá | Concurso de Jóvenes Cardiólogos

That is the reason why we share below those presentations, thanking these professionals for their contribution to our mission: boosting the development of interventional cardiology in Latin America.

SOLACI also thanks all attendees (physicians, specialists in hemodynamics, technicians, and nurses), the Panamanian Society of Cardiology, and the Panamanian Association of Hemodynamics and Interventional Cardiology (APACI), as well as all the people who took part in the organization, for their generosity and hospitality during our stay in their beautiful country.

See the 2019 Panama Sessions highlighted presentations below

Dr. Néstor Fernández | The Importance of Echocardiography in the Cath Lab“.

 

 

Dra. Scarlett G. Sinisterra | Congenital Heart Disease in Panama“.

 

 

Dr. Andrés Iñiguez | Stent Thrombosis with a ‘Surprise”“.

 

 

Dr. Andrés Iñiguez | Antiplatelet Therapy and STENTS Adequate for PCI in Patients at High Risk for Bleeding“.

 

 

Dr. Andrés Iñiguez | Percutaneous Aortic Prosthesis Implantation“.

 

 

Dr. Juan Carmelo Wong Díaz | Epidemiology, Diagnosis, and Prognosis for Peripheral Arterial Disease“.

 

 

Dr. Luis Virgen | Optimal Management of Stable Peripheral Arterial Disease“.

 

 

Dr. Luis Alberto Urna | NSTEMI in 2019. When Should We Intervene?“.

 

 

Dr. Luis Alberto Urna | Fibrinolysis vs. Primary Angioplasty: From Guidelines to Real World“.

 

 

Dr. Francisco Somoza | Massive Pulmonary Thromboembolism Plus Heart Failure. Successful Thrombolysis“.

 

 

Dr. Daniel Meneses | Veins: The Dark Side of Interventional Cardiology“.

 

 

Dr. Luis Guzmán | Chronic Total Occlusions“.

 

 

Dr. Luis Guzmán | “High Risk PCI: Patient Selection and LVAD’s “.

 

 

Dr. Luis Guzmán | “Cardiogenic Shock: A Multidisciplinary Approach “.

 

 

Dr. Mauricio Cohen | LMCA Angioplasty: The Role of Intracoronary Imaging“.

 

 

Dr. Mauricio Cohen | Complications in TAVR: Lessons of a Clinical Case“.

 

 

Dr. Omar Santaera | Stable Coronary Artery Disease. Coronary Catheterization and Revascularization in Multivessel Disease“.

 

 

Dr. Julio Cesar Altamirano | Coronary Angioplasty: A Successful Procedure with Allies in Pharmacological Therapy“.

 

 

Dr. José Luis Leiva Pons | Networks for Pre-Hospital Care in STEMI: The ‘Código Infarto’ Strategy in Mexico“.

 

 

Dr. Antonio Dager | “TAVR for Aortic Insufficiency – Strategic Approach I&II”.

 

 

Dr. Antonio Dager | “TAVR for Aortic Insufficiency – Strategic Approach I&II”.

 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...